Dilution Intelligence for Nasdaq & NYSE StocksShareStructure.io ↗

ShareStructure News

The Filing Desk · Sunday, November 22, 2026
← The Filing Desk

ZCMD's Share Count Rose 200x in Nine Months Across Four Reverse Splits

With 6.7 billion shares authorized against just 4.2 million outstanding, Zhongchao's structural architecture leaves enormous room for further issuance — and shareholders have already pre-approved more consolidations through 2029.

By ShareStructure Research Desk·

Zhongchao Inc. (NASDAQ: ZCMD), a China-based healthcare information services company, is drawing attention from traders — and its share structure tells a striking story of serial reset and reissuance.

The single most important structural fact: split-adjusted shares outstanding grew from roughly 20,759 at year-end 2025 to about 4.23 million today. That is approximately a 200-fold increase in nine months, driven by three offerings in about eight weeks and a large compensation award to the CEO.

The Reverse-Split Cycle

ZCMD executed four reverse splits in 2026 alone — 1-for-8 in March, 1-for-31 in June, 1-for-3 later in June, and 1-for-2 on October 2. Including an earlier 1-for-10 in February 2024, the cumulative consolidation ratio is 14,880-to-1. Each reset shrank the share count, and each was followed by fresh issuance that expanded it again. Shareholders have already approved authority for additional consolidations at ratios from 2:1 to 31.25:1 through February 2029, meaning the cycle can repeat without another vote.

Float and Overhang

The tradeable public float sits at about 2.88 million shares — 68% of the 4.23 million outstanding. Adding 202,728 pre-funded warrants — warrants with a near-zero exercise price ($0.002) that function almost identically to issued shares — brings effective supply to roughly 3.08 million.

The largest single overhang is an Additional Allocation Option — a right held by July 2026 offering investors to purchase up to 4.32 million additional shares at $2.20. That block alone equals 150% of the entire float. It is expected to expire around October 5, 2026; investors should check for a 6-K confirming lapse.

Separately, warrants from a June 2026 best-efforts offering — a deal in which the underwriter sells shares on a "best available" basis with no guarantee of full placement — remain outstanding in an undisclosed quantity. Those warrants may carry a zero-exercise-price alternative cashless feature floored at 20% of a reference price, effectively making them variable-rate instruments. The prospectus itself warned that Nasdaq could object to the structure on public-interest grounds.

Shelf Capacity

ZCMD has an active F-3 shelf registration — a pre-filed SEC statement allowing quick future securities sales — with $294.5 million of capacity remaining. That is roughly 35 times the company's approximately $8.4 million market cap. Baby-shelf rules cap actual use at one-third of public float value per twelve-month period, but the company took down $5.5 million across two registered directs — offerings of already-registered shares sold directly to investors — in July and August through Univest Securities, which holds a right of first refusal on future financings through approximately March 2027.

Insider Positioning

Two days before the discounted July raise, 2.5 million Class A and 200,000 Class B shares (pre-split) were issued to the CEO's vehicle for services, with no cash consideration. After the October split, that is about 1.35 million shares — roughly 32% of outstanding. The Class A portion becomes eligible for resale under Rule 144 around January 2027, subject to affiliate volume limits. The CEO's Class B shares carry 1,000 votes each, giving him 96–99% of voting power, so public-share dilution does not diminish his control.

Dilution Risk Grade: 6/10 — ELEVATED

The score reflects extreme recent issuance activity and historical pattern risk, partially offset by the absence of toxic convertible notes or preferred stock. The authorized share count of 6.72 billion — roughly 1,588 times shares currently outstanding — provides the structural ceiling for what comes next.

The Morning Brief · Free

The small-caps in play, before the open.

A free premarket dispatch from the ShareStructure News desk — the movers that matter, with the dilution read most traders miss.

Free · No spam · Unsubscribe anytime

ShareStructure provides algorithmic, data-driven analysis of public SEC filings and does not provide investment advice. ShareStructure receives no compensation from the companies it covers. An affiliated entity (Darrow Group) provides paid investor-relations services to some public companies; ShareStructure does not publish coverage of those companies while an engagement is active. Analysis is derived from primary-source filings and is not a recommendation to buy or sell any security.